P-117 CONTINUOUS INTRAVENOUS TACROLIMUS FOR LIVER TRANSPLANT RECIPIENTS: IMPLEMENTATION STRATEGY AND CLINICAL OUTCOMES

P-117 CONTINUOUS INTRAVENOUS TACROLIMUS FOR LIVER TRANSPLANT RECIPIENTS: IMPLEMENTATION STRATEGY AND CLINICAL OUTCOMES

Conflict of interest: No Introduction and Objectives: Tacrolimus is the cornerstone of immunosuppression following liver transplantation (LT). In patients with prolonged orotracheal intubation, enteral administration (oral, nasogastric or sublingual) can result in variable pharmacokinetics and troug...

Full description

Saved in:
Bibliographic Details
Main Authors: CAMILO ANDRES TORRES LONDOÑO, ANDRES FERNANDO RODRIGUEZ GUTIERREZ, Josefina Pages, Alejandra Estefania Calizaya Astoraque, Marcelo Silva, Federico Piñero, Martin Fauda, MANUEL MENDIZABAL
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Annals of Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268124005143
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items